Cell Viability Assays Market by Product and Geography - Forecast and Analysis 2020-2024

The cell viability assays market size has the potential to grow by USD 1.40 billion during 2020-2024, and the market’s growth momentum will accelerate during the forecast period.

This report provides a detailed analysis of the market by product (consumables and instruments) and geography (North America, APAC, Europe, South America, and MEA). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors, including Agilent Technologies Inc., Becton, Dickinson and Co., Bio-Rad Laboratories Inc., Biotium Inc., Danaher Corp., General Electric Co., Merck KGaA, PerkinElmer Inc., Promega Corp., and Thermo Fisher Scientific Inc.

Market Overview

Market Competitive Analysis

The market is fragmented, and the degree of fragmentation will decrease during the forecast period. Danaher Corp., General Electric Co., Merck KGaA, PerkinElmer Inc., Promega Corp., and Thermo Fisher Scientific Inc. are some of the major market participants. Although the growing emphasis on timely diagnosis of diseases will offer immense growth opportunities, limitations associated with cell viability assays will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

To help clients improve their market position, this cell viability assays market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of these companies. The report also covers details on the market’s competitive landscape and offers information on the products offered by various companies. Moreover, this cell viability assays market analysis report also provides information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.

This report provides information on the production, sustainability, and prospects of several leading companies, including:

• Agilent Technologies Inc.
• Becton
• Dickinson and Co.
• Bio-Rad Laboratories Inc.
• Biotium Inc.
• Danaher Corp.
• General Electric Co.
• Merck KGaA
• PerkinElmer Inc.
• Promega Corp.
• Thermo Fisher Scientific Inc.

Cell Viability Assays Market: Segmentation by Region

Europe will offer several growth opportunities to market vendors during the forecast period. The growing focus on stem cell research, increasing emphasis on timely diagnosis, high healthcare spending, and well-established healthcare infrastructure will significantly influence cell viability assays market growth in this region.

30% of the market’s growth will originate from Europe during the forecast period. Germany and France are the key markets for cell viability assays in Europe. Market growth in this region will be faster than the growth of the market in other regions.

Cell Viability Assays Market: Segmentation by Product

The high adoption of reagents and kits in cell viability assays and their cost effectiveness will boost the growth of consumables segment during the forecast period. Market growth in this segment will be faster than the growth of the market in the instruments segment. This report provides an accurate prediction of the contribution of all the segments to the growth of the cell viability assays market size.

Cell Viability Assays Market: Key Drivers and Trends

The high incidence and prevalence of cancer is one of the key factors driving global cell viability assay market growth. The high prevalence of cancer has led to cancer research activities that explore advanced technologies for accurate diagnosis and effective treatment. This has increased the demand for cell viability and proliferation assays, which are used in studies evaluating the effect of potential anti-cancer therapeutics on numerous cell lines. The large oncology patient cohort required multiple physician visits and numerous diagnostic tests for accurate interpretation of cancer symptoms, which is consequently driving the market growth. The growing patient pools also offers opportunities for use of cell viability assays in cancer research and diagnostic testing, thereby driving market growth.

• The application of cell viability assays in drug discovery process is a major trend boosting the growth of cell viability assays market.
• Cell viability and cytotoxicity assays are rapid and efficient methods to evaluate the effects of the chemical compound present in novel therapeutics on a human cell line, thus driving their demand for chemicals and drug screening tests.
• Cell viability assays provide a cost-effective and safe option for obtaining information about drug tolerance and associated biological effects, leading to their usage in wide range of applications in pharmaceutical development.  
• The continuous expansion of these assays to newer fields like neuroscience and immunology is increasing their demand, positively impacting cell viability assays market growth.
• During 2020-2024, the market will register a CAGR of over 8%.  

Cell Viability Assays Market: Key Highlights of the Report for the Forecast Period 2020-2024

• CAGR of the market during the forecast period 2020-2024
• Detailed information on factors that will drive cell viability assays market growth during the next five years
• Precise estimation of the cell viability assays market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the cell viability assays market industry across North America, APAC, Europe, South America, and MEA
• A thorough analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of cell viability assays market vendors